PELVIC EXENTERATION FOR LOCALLY ADVANCED PELVIC MALIGNANCIES TREATMENT
The aim of the study is to analyze the major complications after exenteration of pelvic malignancies. Twenty-four patients with pelvic malignancy underwent pelvic exenteration (PE) between 2012 and 2014. The most frequent indications for PE were cervical cancer (primary and recurrent) - in 5 cases, rectal cancer (primary and recurrent) - in 6 cases, bladder cancer (end-stage) - in 8 cases.Total frequency of complications was 11 (45,8%) cases, mortality rate was 12,5%, of which inter-operative mortality accounted for 4,1%.PE plays a key role in a complex treatment of patients with locally advanced pelvic tumors. PE remains a serious surgery due to development of early and late postoperational complications.